[Cytostatic and antimetabolite therapy in chronic inflammatory joint diseases and collagen diseases].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000473:pathology; D001379:Azathioprine / Q000627:therapeutic use*; D001706:Biopsy; D003095:Collagen Diseases / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007275:Injections, Intravenous; D008727:Methotrexate / Q000627:therapeutic use*; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011033:Podophyllin / Q000627:therapeutic use; D011035:Podophyllum / Q000627:therapeutic use*; D013583:Synovial Membrane / Q000473:pathology; D014228:Triaziquone / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D011033:Podophyllin; D014228:Triaziquone; D001379:Azathioprine; D008727:Methotrexate
Zytostatika- und Antimetaboliten-Therapie bei chronisch entzündlichen Gelenkerkrankungen und bei Kollagenosen.